Drug
6mhp
6mhp: highest development phase Phase 1/2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| 6MHP NCT04364230 | Phase 1/2 | Melanoma |
Latest
No recent events.
Follow 6mhp on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.